GLP-1 Medicines Review: South Africa Moves to Expand Access

Original Article by Tamar Kahn | Business Day | 1 December 2025

NEMLC begins a GLP-1 medicines review to assess affordability and potential inclusion in the public health sector for diabetes and obesity

NEMLC begins a GLP-1 medicines review to assess affordability and potential inclusion in the public health sector for diabetes and obesity

Subscription Required

You must be a subscriber to access all of this content.

View Subscriptions

Already a subscriber? Log in here